ICCC

NASDAQStock

ImmuCell Corporation

$6.45-0.18 (-2.71%)

52-Week Range

$4.56
$7.60

Key Stats

Market Cap

P/E Ratio

Dividend Yield

Beta

0.30

Volume

16.9K

Avg Volume

11.7K

Performance

1M

+0.15%

3M

+7.98%

6M

+11.43%

YTD

+11.99%

1Y

+32.87%

3Y

+32.60%

5Y

-36.86%

Price Chart

ETF Exposure

ICCC is held by 13 ETFs

ETFFund NameWeight
IWCiShares Micro-Cap ETF0.01%
VXFVanguard Extended Market ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
DFATDimensional - US Targeted Value ETF0.00%
DFSUDimensional - US Sustainability Core 1 ETF0.00%
DXUVDimensional - US Vector Equity ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About ICCC ETF Exposure

ImmuCell Corporation (ICCC) is held by 13 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $6.45. Investors can gain exposure to ICCC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ICCC, sorted by portfolio weight.